In a Russian clinical study of ischemic stroke patients, Semax-treated individuals showed improved neurological outcome measures compared to a control group. Independent replication is lacking, and effect sizes were not extractable from the available source.
Zhurnal nevrologii i psikhiatrii 2018 · ClinicalBaseline
Ischemic stroke patients enrolled
Treatment
Semax administered across stroke stages
Follow-up
Neurological outcomes assessed
Result
Improved outcomes vs. control group
Gusev et al., 2018 — single Russian clinical study; quantitative effect sizes not available in public abstract. RUO only.









